No photo of William Weiss

View Scopus Profile

William Weiss, MS

  • 2090 Citations
  • 25 h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.

Education/Academic qualification

MS in Biology, Fairleigh Dickinson University

Award Date: 1 Jan 2001

BS in Microbiology, Rutgers University

Award Date: 1 Jan 2000

Fingerprint Dive into the research topics where William Weiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

FCCDC 2019-02: Model Development and Test Article Efficacy in a Disseminated Aspergillus and Cutaneous Fungal Infection (Aspergillus & Fusarium) Models

Simecka, J. & Weiss, W.

Fox Chase Chemical Diversity Center, Inc

22/10/19 → 21/10/20

Project: Research

Development and Validation of a Chronic Murine Lung Infection Model with S. Aureus

Simecka, J. & Weiss, W.

Janssen Pharmaceuticals

17/10/19 → 16/10/20

Project: Research

Pre-Clinical Services Agreements

Simecka, J. & Weiss, W.

Pre-Clinical Services Funding Pool

1/09/19 → 31/08/20

Project: Research

Development and Validation of a Chronic Murine Lung Infection Model with P. aeruginosa

Simecka, J. & Weiss, W.

Janssen Pharmaceuticals

18/04/19 → 17/04/20

Project: Research

Development and Evaluation of Test Articles in a Cutaneous Fungal Model with Aspergillus Fumigatus

Simecka, J. & Weiss, W.

Fox Chase Chemical Diversity Center, Inc

31/10/18 → 30/10/19

Project: Research

Research Output

  • 2090 Citations
  • 25 h-Index
  • 54 Article

DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones

Saint-Lu, N., Burdet, C., Sablier-Gallis, F., Corbel, T., Nevière, A., Sayah-Jeanne, S., Pulse, M., Weiss, W., Ferreira, S., Andremont, A., Mentré, F. & de Gunzburg, J., 1 Jan 2020, In : Antimicrobial agents and chemotherapy. 64, 1, e01196-19.

Research output: Contribution to journal › Article

    • In Vivo Efficacy of Novel Monobactam LYS228 in Murine Models of Carbapenemase-Producing Klebsiella pneumoniae Infection

    Weiss, W. J., Pulse, M. E., Nguyen, P. & Growcott, E. J., Apr 2019, In : Antimicrobial agents and chemotherapy. 63, 4, e02214-18.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Pharmacological, toxicological, and dose range assessment of OG716, a novel lantibiotic for the treatment of clostridium difficile-associated infection

    Pulse, M. E., Weiss, W. J., Kers, J. A., DeFusco, A. W., Park, J. H. & Handfield, M., Apr 2019, In : Antimicrobial agents and chemotherapy. 63, 4, e01904-18.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Treatment and prevention of recurrent Clostridium difficile infection with functionalized bovine antibody-enriched whey in a hamster primary infection model

    Heidebrecht, H. J., Weiss, W. J., Pulse, M., Lange, A., Gisch, K., Kliem, H., Mann, S., Pfaffl, M. W., Kulozik, U. & von Eichel-Streiber, C., Feb 2019, In : Toxins. 11, 2, 98.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Activity of meropenem-vaborbactam against carbapenem- resistant enterobacteriaceae in a murine model of pyelonephritis

    Weiss, W. J., Pulse, M. E., Nguyen, P., Peterson, K., Silva, J., Simecka, J. W., Valtierra, D., Sabet, M. & Griffith, D. C., Jan 2018, In : Antimicrobial agents and chemotherapy. 62, 1, e01439.

    Research output: Contribution to journal › Article

    • 7 Scopus citations